Since some cancer cells express only a few neoantigens, i.e., proteins absent in healthy tissues and formed due to tumor-specific alterations on the tumor cell surface, such cross-presentation of Hsp–peptide complexes expands the spectrum of available immune system targets [205]. The gene discussed is HSP90B2P; the disease is cancer.